中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
34期
90-91
,共2页
依达拉奉%NIHSS评分量表%醒脑静注射液
依達拉奉%NIHSS評分量錶%醒腦靜註射液
의체랍봉%NIHSS평분량표%성뇌정주사액
Edaravone%NIHSS rating scale%Xing Nao Jing injection
目的：探讨依达拉奉治疗急性脑出血患者的临床疗效。方法：2013年2月-2014年4月收治急性脑出血患者126例，随机分成对照组和观察组，各63例，对照组按照降颅压、止血、抗感染和维持水电解质平衡治疗原则，给予醒脑静注射液20 mL+5%葡萄糖注射液250 mL，静滴，糖尿病患者用0.9%氯化钠注射液静滴；观察组在对照组的基础上给予依达拉奉注射液30 mg+0.9%氯化钠注射液静滴。两组均连续治疗21 d。结果：观察组基本痊愈19例，显著进步29例，进步12例，无效2例，死亡1例，总有效率95.2%；对照组基本痊愈15例，显著进步23例，进步11例，无效13例，死亡1例，总有效率77.8%，两组比较差异有统计学意义(P＜0.05)。观察组治疗前NIHSS评分(11.2±1.8)分，治疗后(3.4±0.6)分，对照组治疗前NIHSS评分(11.2±1.7)分，治疗后(5.3±0.9)分，两组治疗前后比较差异有统计学意义(P＜0.05)，两组治疗后比较差异有统计学意义(P＜0.05)。结论：依达拉奉治疗急性脑出血患者疗效显著，值得推广。
目的：探討依達拉奉治療急性腦齣血患者的臨床療效。方法：2013年2月-2014年4月收治急性腦齣血患者126例，隨機分成對照組和觀察組，各63例，對照組按照降顱壓、止血、抗感染和維持水電解質平衡治療原則，給予醒腦靜註射液20 mL+5%葡萄糖註射液250 mL，靜滴，糖尿病患者用0.9%氯化鈉註射液靜滴；觀察組在對照組的基礎上給予依達拉奉註射液30 mg+0.9%氯化鈉註射液靜滴。兩組均連續治療21 d。結果：觀察組基本痊愈19例，顯著進步29例，進步12例，無效2例，死亡1例，總有效率95.2%；對照組基本痊愈15例，顯著進步23例，進步11例，無效13例，死亡1例，總有效率77.8%，兩組比較差異有統計學意義(P＜0.05)。觀察組治療前NIHSS評分(11.2±1.8)分，治療後(3.4±0.6)分，對照組治療前NIHSS評分(11.2±1.7)分，治療後(5.3±0.9)分，兩組治療前後比較差異有統計學意義(P＜0.05)，兩組治療後比較差異有統計學意義(P＜0.05)。結論：依達拉奉治療急性腦齣血患者療效顯著，值得推廣。
목적：탐토의체랍봉치료급성뇌출혈환자적림상료효。방법：2013년2월-2014년4월수치급성뇌출혈환자126례，수궤분성대조조화관찰조，각63례，대조조안조강로압、지혈、항감염화유지수전해질평형치료원칙，급여성뇌정주사액20 mL+5%포도당주사액250 mL，정적，당뇨병환자용0.9%록화납주사액정적；관찰조재대조조적기출상급여의체랍봉주사액30 mg+0.9%록화납주사액정적。량조균련속치료21 d。결과：관찰조기본전유19례，현저진보29례，진보12례，무효2례，사망1례，총유효솔95.2%；대조조기본전유15례，현저진보23례，진보11례，무효13례，사망1례，총유효솔77.8%，량조비교차이유통계학의의(P＜0.05)。관찰조치료전NIHSS평분(11.2±1.8)분，치료후(3.4±0.6)분，대조조치료전NIHSS평분(11.2±1.7)분，치료후(5.3±0.9)분，량조치료전후비교차이유통계학의의(P＜0.05)，량조치료후비교차이유통계학의의(P＜0.05)。결론：의체랍봉치료급성뇌출혈환자료효현저，치득추엄。
Objective:To explore the clinical effect of edaravone in the treatment of patients with acute cerebral hemorrhage. Methods:126 patients with acute cerebral hemorrhage were selected from February 2013 to April 2014.They were randomly divided into the control group and the observation group with 63 cases in each group.The control group were given reducing intracranial pressure,hemostasis,anti infection and maintaining water and electrolyte balance treatment,and Xing Nao Jing injection 20 mL+5% glucose injection 250 mL for intravenous drip.Diabetic patients were treated by 0.9%NS intravenous drip. The observation group were given edaravone injection 30 mg+0.9%NS by intravenous drip on the basis of the control group.Two groups were treated for 21 days.Results:In the observation group,19 cases were basically cured;29 cases were significant progress;12 cases were progress;2 cases were invalid;1 case was died;the total efficiency was 95.2%.In the control group,15 cases were basically cured;23 cases were significant progress;11 cases were progress;13 cases were invalid;1 case was died;the total efficiency was 77.8%.The difference was statistically significant(P<0.05).In the observation group,before treatment NIHSS score was (11.2+1.8) points;after treatment the score was (3.4+0.6) points.In the control group,before treatment NIHSS score was (11.2+1.7) points;after treatment score was (5.3 + 0.9) points.Compared the two groups before and after treatment,the difference was statistically significant(P<0.05);compared the two groups after treatment,the difference was statistically significant(P<0.05). Conclusion:The clinical effect of edaravone in treatment of patients with acute cerebral hemorrhage is significant.It is worthy of popularization.
